LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

计划入组 64 人 · 首次发布于 2005 年 9 月 12 日

A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

计划入组 26 人 · 首次发布于 2023 年 6 月 2 日

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

计划入组 2 人 · 首次发布于 2013 年 6 月 17 日

FAV-201

anti-CD30 CAR T-cell therapy (Cutaneous T-cell lymphoma)

anti-CD3/anti-HSP70 bispecific T cell-engager (T-cell lymphoma/multiple myeloma)

Viridian Metals Inc

United States

Soligenix

United States

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

T-Cell Lymphoma Pipeline Shows Promise with Novel Therapies and Regulatory Support

Personalized Treatment Approaches Show Promise in T-Cell Lymphoma Therapy

CAR T-Cell Therapy AUTO4 Shows Promise in Treating Peripheral T-Cell Lymphoma